These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6393265)

  • 41. Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus.
    Gharavi AE; Elkon KB; Schifferli JA; Hughes GR
    J Clin Lab Immunol; 1981 Nov; 6(3):251-5. PubMed ID: 7338885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Problems in the demonstration immune complexes].
    Sedlacek HH; Pernice W; Seiler FR
    Internist (Berl); 1980 Apr; 21(4):220-6. PubMed ID: 6448232
    [No Abstract]   [Full Text] [Related]  

  • 43. [Relationship of renal histopathology to immunoglobulin classes and complement fixation of anti-native DNA antibodies and components of immune complexes in patients with systemic lupus erythematosus (author's transl)].
    Hashimoto H; Utagawa Y; Yamagata J; Okada T; Shiokawa Y; Suzuki S; Tomiyama T
    Ryumachi; 1981 Sep; 21(5):366-74. PubMed ID: 6977194
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical significance of serial measurement of immune complexes in the management of SLE (author's transl)].
    Sakurai T; Kono I; Kabashima T; Yamane K; Kashiwagi H
    Ryumachi; 1980 Sep; 20(4):247-52. PubMed ID: 7444662
    [No Abstract]   [Full Text] [Related]  

  • 45. [Use of the C3b-RBC binding technic for the determination of immune complexes in patients with various pathologies].
    Garberi JC; Trini E; Barañao RI; Rumi LS
    Sangre (Barc); 1986; 31(6):685-92. PubMed ID: 2951879
    [No Abstract]   [Full Text] [Related]  

  • 46. C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus.
    Traustadottir KH; Sigfusson A; Steinsson K; Erlendsson K
    J Rheumatol; 2002 Nov; 29(11):2359-66. PubMed ID: 12415592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of three assays for anti-DNA with three assays for the measurement of the role of complement in systemic lupus erythematosus in adolescents.
    Miller JJ; Hsu YP; Osborne CL; Kredich DW
    J Rheumatol; 1980; 7(5):660-4. PubMed ID: 7003143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Complement enables the physiological elimination of immune complexes].
    Schifferli JA
    Ther Umsch; 1988 Feb; 45(2):74-8. PubMed ID: 3358245
    [No Abstract]   [Full Text] [Related]  

  • 49. [Methods for measuring the circulating immune complexes].
    Muratsugu M; Makino M
    Rinsho Byori; 1983 Mar; 31(3):262-7. PubMed ID: 6345866
    [No Abstract]   [Full Text] [Related]  

  • 50. [Detection of immune complex by Fc receptor].
    Hashimoto Y; Tanimoto K
    Nihon Rinsho; 1979; 37(4):904-10. PubMed ID: 449074
    [No Abstract]   [Full Text] [Related]  

  • 51. [Detection of antigen-antibody complexes by various methods and their significance for diagnosis and therapy. The Clinico-Immunologic Diagnosis Task Force, East Germany].
    Z Erkr Atmungsorgane; 1982; 158(3):349-64. PubMed ID: 7136054
    [No Abstract]   [Full Text] [Related]  

  • 52. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
    Valentijn RM; van Es LA; Daha MR
    J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune complex mediated rheumatic diseases.
    Somer T; Wallace DJ; Fan PT
    Ann Clin Res; 1980 Apr; 12(2):77-86. PubMed ID: 6449901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complement activation and vascular injury in systemic lupus erythematosus.
    Abramson S; Belmont HM; Hopkins P; Buyon J; Winchester R; Weissmann G
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():43-6. PubMed ID: 2886660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparison between platelet aggregation method and Clq solid-phase radioimmunoassay].
    Kasukawa R; Sato M; Suzuki H; Yoshida T
    Nihon Rinsho; 1979 May; 37(5):1132-7. PubMed ID: 470166
    [No Abstract]   [Full Text] [Related]  

  • 56. Immune complex clearance by complement receptor type 1 in SLE.
    Kavai M
    Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoantibodies against C1q in systemic lupus erythematosus.
    Siegert CE; Breedveld FC; Daha MR
    Behring Inst Mitt; 1993 Dec; (93):279-86. PubMed ID: 8172577
    [No Abstract]   [Full Text] [Related]  

  • 58. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Determination of circulating immune complexes in hematological diseases by Clq ELISA (a microplate method)].
    Hayashi S; Oshida M; Tsubakio T; Kurata Y
    Rinsho Byori; 1983 Jun; 31(6):621-4. PubMed ID: 6361331
    [No Abstract]   [Full Text] [Related]  

  • 60. Studies of circulating immune complexes in ankylosing spondylitis.
    Kinsella TD; Lanteigne C; Lewkonia RM; Fritzler MJ
    Clin Invest Med; 1982; 5(4):223-30. PubMed ID: 7160109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.